Welcome to Iris Biotech
For better service please confirm your country and language we detected.
For better service please confirm your country and language we detected.
Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Continue to Iris Biotech GmbHSend request to US distributorChemischer Name: 1-(9H-fluoren-9-yl)-4,7,10,13,16,19,22-heptamethyl-3,6,9,12,15,18,21-heptaoxo-2-oxa-4,7,10,13,16,19,22-heptaazatetracosan-24-oic acid // Synonyme: Fmoc-(Sar)7, Fmoc-heptasarcosine, Fmoc-(Sar)7-OH, Fmoc-Sar-Sar-Sar-Sar-Sar-Sar-Sar-OH
Ab 110,00 €
Used as a monodisperse poly-Sarcosine linker/building-block in solution-phase and solid-phase peptide synthesis.
WO 2019081455 A1
Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform; L. Conilh, G. Fournet, E. Fourmaux, A. Murcia, E.-L. Matera, B. Joseph, C. Dumontet, W. Viricel; Pharmaceuticals 2021, 14(3): 247. https://doi.org/10.3390/ph14030247
Patents by Bicycle Therapeutics:
WO2021250418A1
WO2019193328A1
WO2013050617A1
US20220135614A1
WO2019162682A1
Patents and publications by Biontech:
WO2021191265A1
Polysarcosine-Functionalized Lipid Nanoparticles for Therapeutic mRNA Delivery; S. S. Nogueira, A. Schlegel, K. Maxeiner, B. Weber, M. Barz, M. A. Schroer, C. E. Blanchet, D. I. Svergun, S. Ramishetti, D. Peer, P. Langguth, U. Sahin, H. Haas; ACS Appl. Nano Mater. 2020, 3(11): 10634–10645. https://doi.org/10.1021/acsanm.0c01834
Bitte senden Sie mir mehr Informationen über